Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00044408
Status:
COMPLETED
Last Update Posted:
2016-07-26
First Post:
2002-08-28
Brief Title:
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
Sponsor:
Chromaderm Inc
Organization:
Chromaderm Inc
Study Overview
Official Title:
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status:
COMPLETED
Status Verified Date:
2016-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this protocol is to determine if an investigational drug known as LY333531 is effective in treating nerve malfunction in diabetes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| B7A-MC-MBCW | None | None | None |